News
Lead Product, QRX003, Being Tested in Two Active Registrational Clinical Studies for Netherton Syndrome Across the U.S., ...
Investing.com -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) stock rose 2.4% following the company’s update on its development product portfolio, highlighting progress in its lead product for Netherton ...
Lead Product, QRX003, Being Tested in Two Active Registrational Clinical Studies for Netherton Syndrome Across the U.S., ...
Dermatologists and other skin care experts said these face serums can address a variety of skin care issues, from wrinkles and dark spots to dryness and acne.
New understanding of a receptor key to allergic responses and anaphylaxis in conditions like asthma could offer a new treatment target for sufferers of a variety of conditions.
A new therapy support group at Jefferson Moss-Magee Rehabilitation helps patients regain independence and identity with ...
Dr. Rikka Banayat, Owner and CEO of Luxe Rejuvena Aesthetics & Wellness, was back with us this morning to share about the Hydroderm Radiofrequency facial. It’s a game-changing facial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results